News for Healthier Living

New AI framework offers reliable, cost-effective prediction of PIK3CA mutations in breast cancer

Accurate detection of PIK3CA mutations is essential for personalizing breast cancer treatment, particularly with PI3K-targeted therapies. However, conventional molecular testing is not always accessible, and single-modality prediction models show limited performance. This study introduces a multimodal artificial intelligence framework that combines digital pathology and structured clinical data, providing a robust solution for predicting PIK3CA mutation status in breast cancer. By integrating whole-slide imaging (WSI) and clinical variables, the proposed deep learning model offers a cost-effective, scalable, and reliable alternative to traditional sequencing, with strong performance across multiple clinical datasets.

April 20, 2026


May 1 2026

April 30 2026

April 29 2026

April 28 2026

April 27 2026

April 26 2026

April 25 2026

April 24 2026

April 23 2026

April 22 2026

April 21 2026

April 20 2026

April 19 2026

April 18 2026